Viewing Study NCT02077933

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-03-09 @ 4:04 AM
Study NCT ID: NCT02077933
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2014-02-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
None Breast Neoplasms View
None Kidney Neoplasms View
None Pancreatic Neuroendocine Neoplasms (pNETs) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid tumors View
None renal cell carcinoma (RCC) View
None pancreatic neuroendocrine tumors View
None breast cancer View
None PI3K inhibitor View
None BYL719 View
None alpelisib View
None everolimus View
None exemestane View